2014
DOI: 10.1074/jbc.m114.565762
|View full text |Cite
|
Sign up to set email alerts
|

The CpxR/CpxA Two-component Regulatory System Up-regulates the Multidrug Resistance Cascade to Facilitate Escherichia coli Resistance to a Model Antimicrobial Peptide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
55
1
2

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 102 publications
(60 citation statements)
references
References 46 publications
2
55
1
2
Order By: Relevance
“…OmpR in E. coli reciprocally regulates ompF and ompC depending on the osmotic conditions of the environment (56). CpxR in E. coli promotes expression of marR and represses expression of ung (57,58). CvsR appears to be similar in its ability to promote and repress expression of different genes.…”
Section: Discussionmentioning
confidence: 99%
“…OmpR in E. coli reciprocally regulates ompF and ompC depending on the osmotic conditions of the environment (56). CpxR in E. coli promotes expression of marR and represses expression of ung (57,58). CvsR appears to be similar in its ability to promote and repress expression of different genes.…”
Section: Discussionmentioning
confidence: 99%
“…A 2CSTS that acts upon the transcription of tier III genes is CpxA/CpxR. This 2CSTS responds to envelope stress, inhibits LEE gene transcription (82), and activates the synthesis pathway that leads to the production of an antimicrobial peptide that causes multidrug resistance (83). Direct binding of CpxR-P to the promoter regions of the motA and tsr operons has been shown (84) and so has transcriptional repression of csgD by CpxR (33,85).…”
Section: Additional Downstream Regulation Of Flagellar Genesmentioning
confidence: 99%
“…Strain A5-1 had a 6,115-bp deletion including marRAB (ydeA, marRAB, eamA, and ydeEH). Regulators of Mar showed point mutations in strain G5-2 (mar paralog rob [26]) and in strain A1-1 (two-component activator cpxA [59]). Additional mutations appeared in other multidrug efflux systems: emrA and emrY (32,60), mdtA and deletions covering mdtEF (60), and yeaS (leuE) leucine export (61).…”
mentioning
confidence: 99%